The 10-second takeaway
For the quarter ended Feb. 28 (Q1), Xyratex beat expectations on revenues and exceeded expectations on earnings per share.
Compared to the prior-year quarter, revenue dropped significantly. Non-GAAP earnings per share dropped to a loss. GAAP earnings per share dropped to a loss.
Gross margins grew, operating margins dropped, net margins dropped.
Xyratex tallied revenue of $195.6 million. The three analysts polled by S&P Capital IQ predicted revenue of $177.3 million on the same basis. GAAP reported sales were 34% lower than the prior-year quarter's $295.7 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at -$0.13. The two earnings estimates compiled by S&P Capital IQ predicted -$0.21 per share. Non-GAAP EPS were -$0.13 for Q1 compared to $0.40 per share for the prior-year quarter. GAAP EPS were -$0.19 for Q1 versus $0.38 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 18.9%, 100 basis points better than the prior-year quarter. Operating margin was -2.9%, 650 basis points worse than the prior-year quarter. Net margin was -2.6%, 630 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $202.7 million. On the bottom line, the average EPS estimate is -$0.13.
Next year's average estimate for revenue is $872.1 million. The average EPS estimate is $0.01.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 260 members out of 279 rating the stock outperform, and 19 members rating it underperform. Among 70 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 63 give Xyratex a green thumbs-up, and seven give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Xyratex is outperform, with an average price target of $11.00.
Is Xyratex the best tech stock for you? You may be missing something obvious. Check out the semiconductor company that Motley Fool analysts expect to lead "The Next Trillion-dollar Revolution." Click here for instant access to this free report.
- Add Xyratex to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.